NCT04291326 is a clinical trial of Transfontanelle ultrasound in Cerebral Blood Flow, sponsored by Seoul National University Hospital.

Who is sponsoring NCT04291326?

NCT04291326 is sponsored by Seoul National University Hospital.

What drugs are being tested in NCT04291326?

Interventions in NCT04291326: Transfontanelle ultrasound.

What condition does NCT04291326 study?

NCT04291326 studies Cerebral Blood Flow.

Is NCT04291326 still recruiting?

NCT04291326 is currently status unknown. Last updated 16 March 2021.

Last reviewed 2021-03-16 · How we verify

NCT04291326

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cerebral Blood Flow Velocity Changes During Laparoscopic Surgery

Status unknown Last updated 16 March 2021

What this trial tests

trial testing Transfontanelle ultrasound in Cerebral Blood Flow in 30 participants. Status unknown.

Timeline

20 March 2020

Primary endpoint
28 December 2021

28 December 2021

Quick facts

Lead sponsor	Seoul National University Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	30
Start date	20 March 2020
Primary completion	28 December 2021
Estimated completion	28 December 2021
Sites	1 location across South Korea

Drugs / interventions tested

Transfontanelle ultrasound

Conditions studied

Cerebral Blood Flow — all drugs for Cerebral Blood Flow →

Sponsor

Seoul National University Hospital

Who can join

Under 2, any sex, with Cerebral Blood Flow. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Little is known about how implementation of pneumoperitoneum contributes to cerebral blood flow in pediatrics. We investigated this question in patients undergoing laparoscopic surgery, hypothesizing that cardiorespiratory changes during this procedure would reduce cerebral perfusion.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cerebral Blood Flow

Currently open trials in the same condition.

NCT07082478 — External Carotid Blood Flow in Individuals With Post-Bariatric Hypoglycemia · recruiting
NCT07057245 — Effects of Protein Supplementation on Brain Function · NA · recruiting
NCT06855407 — Hypertension and Cerebrovascular Hemodynamics in General Anaesthesia · NA · recruiting

Other Seoul National University Hospital trials

Trials by the same sponsor.

NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04291326 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
Last refreshed: 16 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04291326.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing